Inactivation of PTEN by deletion, mutation, epigenetic silencing, or post-translational inactivation has been reported in T-ALL patients, suggesting that activation of the AKT pathway also contributes to the development of T-ALL [13], [53], [54]. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.